During the second half of February, the US DOJ announced two separate enforcement actions related to FCA violations. One case involves a scheme to refer patients for unnecessary healthcare services. The other is related to billing the US Department of Labor (DOL) millions of dollars in unnecessary prescription compound creams.
Register for free to keep reading
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day